Lonza confident of 2020 target for Moderna COVID-19 vaccine supply

Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.

Read the full article here

Related Articles